Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Gamma glutamyl transferase as a biomarker to predict contrast-induced nephropathy among patients with acute coronary syndrome undergoing coronary interventions: a meta-analysis

Title: Gamma glutamyl transferase as a biomarker to predict contrast-induced nephropathy among patients with acute coronary syndrome undergoing coronary interventions: a meta-analysis
Authors: Javid, Mona; Mirdamadi, Arian; Javid, Mohammadreza; Amini-Salehi, Ehsan; Vakilpour, Azin; Keivanlou, Mohammad-Hossein; Porteghali, Parham; Hassanipour, Soheil
Source: Annals of Medicine & Surgery ; volume 85, issue 8, page 4033-4040 ; ISSN 2049-0801
Publisher Information: Ovid Technologies (Wolters Kluwer Health)
Publication Year: 2023
Description: Background and aims: The third most frequent reason for hospitalized acute kidney injury is contrast-induced nephropathy (CIN). Percutaneous coronary intervention (PCI) and coronary angiography (CAG) are two interventions that can result in CIN. In this study, we sought to determine how well gamma-glutamyl transferase (GGT) can predict CIN following CAG and PCI. Method: Two researchers searched through PubMed, Scopus, and Web of Science in November 2022 to find articles that examined GGT levels in CIN patients following PCI or CAG. To rate the quality of the studies, the Joanna Briggs Institute Critical Appraisal Checklist was employed. The Cochran test and I 2 statistics were utilized to assess study heterogeneity. To calculate the number of participants required to reject the null hypothesis, power analysis was used. We evaluated the epidemiologic strength of the results using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE). The authors used Comprehensive Meta-analysis Version 3 to summarize the results. Results: GGT was shown to be considerably greater in patients with CIN according to the meta-analysis’s findings (odds ratio: 3.21, 95% CI: 1.26–8.15, P =0.014); nevertheless, the findings were accompanied by significant heterogeneity (I 2 =91.93%, P
Document Type: article in journal/newspaper
Language: English
DOI: 10.1097/ms9.0000000000000967
DOI: 10.1097/MS9.0000000000000967
Availability: https://doi.org/10.1097/ms9.0000000000000967; https://journals.lww.com/10.1097/MS9.0000000000000967
Rights: http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.82DEF487
Database: BASE